CLPBY
PINK Coloplast A/S Sponsored ADR$6.22 ↓ -0.10 (-1.58%) Trading Down from the previous close of $6.32, $0.14 below the day’s high of $6.36
- YTD change
- -26.82%
- vs 20-day SMA
- -6.26%
- vs 200-day SMA
- -11.00%
Price ranges
Price & Performance
-0.60 (-8.67%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 67.1% away from all-time highs of $18.90
- CLPBY is down 27% since the beginning of the year
- CLPBY is down 29% over the past 12 months
- CLPBY is down 15% over the past 1 month
CLPBY reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -27.9%.
- Previous minute
- +$0.00
- Last hour
- -$0.02
- Last 5 days
- -3.11%
- vs 8-day SMA
- -3.24%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.